Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer
Clinical trial NCT01607905 · COMPLETED
Trial details
- NCT number
- NCT01607905
- Sponsor
- Karyopharm Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-18
- Primary completion
- 2016-03-15
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.